Orasure Tech Stock
Price
Target price
€2.46
€2.46
-1.600%
-0.04
-1.600%
-
03.06.25 / Frankfurt
WKN: 881351 / Symbol: OSUR / Name: OraSure Tech / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Orasure Tech Stock
We can see a decrease in the price for Orasure Tech. Compared to yesterday it has lost -€0.040 (-1.600%).
Pros and Cons of Orasure Tech in the next few years
Pros
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Orasure Tech vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Orasure Tech | -1.600% | 12.613% | -3.101% | -42.130% | -26.901% | -34.555% | -75.490% |
| SI-BONE Inc | -0.610% | 0.613% | 33.333% | 28.125% | 26.154% | - | - |
| scPharmaceuticals | 7.240% | 6.532% | 37.860% | -15.769% | -5.370% | -29.679% | -59.658% |
| Lantheus Holdings Inc | 2.600% | 2.182% | -28.895% | -10.312% | -21.623% | 1.274% | - |
Comments
OraSure Technologies, Inc. (NASDAQ: OSUR) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for OSUR provided by MarketBeat
OraSure Technologies, Inc. (NASDAQ: OSUR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for OSUR provided by MarketBeat
OraSure Technologies, Inc. (NASDAQ: OSUR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for OSUR provided by MarketBeat
News
OraSure Stock: Insiders Bet Big Near 52-Week Low
OraSure Technologies' stock is experiencing significant insider buying activity as multiple executives made substantial investments while shares trade near their 52-week low of €2.69. CEO Carrie
